People

Benjamin C. Kelsey

Associate

Kelsey, Benjamin

Benjamin Kelsey is an associate who focuses his practice on complex tax matters, including taxable and tax-free mergers and acquisitions. His practice also includes executive compensation matters, such as equity compensation, incentive plans and golden parachute issues.

Prior to joining WilmerHale, Mr. Kelsey was a law clerk at a New York law firm where he focused on immigration matters. He also worked as a summer associate at a law firm in New Jersey. While in law school, he served as editor-in-chief of the Boston College International & Comparative Law Review.

Before attending law school, Mr. Kelsey was employed in the alternative investment industry.

Publications & News

View

December 5, 2017

Astellas Acquires Mitobridge Under Existing Collaboration

Astellas Pharma Inc. and Mitobridge, Inc. announced that Astellas has exercised its exclusive option right to acquire Mitobridge under the amended terms of the October 2013 partnership agreement.

August 14, 2017

Massachusetts Issues Proposed Regulations Requiring Remote Sellers to Collect Sales Tax

We previously reported to you that the Massachusetts Department of Revenue (DOR) had revoked Directive 17-1 requiring the collection of Massachusetts sales and use taxes by Internet vendors that meet certain sales thresholds in Massachusetts. The DOR has now issued proposed regulations substantially similar to Directive 17-1.

August 3, 2017

WilmerHale Represents Navient in Acquisition of Duncan Solutions

Navient, a leading asset management and business processing services company, announced the acquisition of Duncan Solutions, a transportation revenue management company serving municipalities and toll authorities.

June 27, 2017

WilmerHale Represents State Street in the Sale of its BlockCross ATS to Instinet

Longstanding client State Street is represented by a team led by Stephanie Evans that includes Livingston Miller, Mark Nylen, Byron Crowe, Nils Remole, Andre Owens, Jeremy Moorehouse, Michael Bevilacqua, Bill Caporizzo, Amy Null and Benjamin Kelsey.

April 3, 2017

WilmerHale Reps Vtesse Inc. in Acquisition by Sucampo

Sucampo Pharmaceuticals, Inc., a global biopharmaceutical company, and Vtesse Inc., a privately-held rare disease company, today announced that Sucampo has acquired Vtesse for upfront consideration of $200 million.

Practices

Skip Navigation Links.

Education

JD, cum laude, Boston College Law School, 2016, Editor-in-Chief, Boston College International & Comparative Law Review

BA, Economics, magna cum laude, and Spanish, cum laude, Tufts University, 2008

Bar Admissions

Massachusetts

Skip Navigation Links.